返回 Agenda
LS20 New Phase in Combatting Antimicrobial Resistance (AMR)
Session Chair(s)
Masahito Nagashima
Head of Clinical Research, Pfizer R&D Japan, Japan
Speaker(s)
Shigeru Omi, MD, PhD
Representative Director, Japan Anti-Tuberculosis Association, Japan
Kazuhiro Tateda, MD, PhD
Professor, Department of Microbiology and Infectious Diseases, Toho University, Japan
Mari Ariyasu
Head of Project Management 4, Senior Director, Shionogi & Co., Ltd., Japan